Literature DB >> 1054061

The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection.

J L Stanford, W D Revill, W J Gunthorpe, J M Grange.   

Abstract

The preparation of a skin test antigen from Mycobacterium ulcerans by ultrasonic disintegration and filtration is described. The reagent, called Burulin, was tested in Africa in normal school children, and in patients with leprosy, tuberculosis or M. ulcerans disease. Those with tuberculosis or M. ulcerans disease were simultaneously tested with Tuberculin PPD. Burulin was found to be highly specific for patients in the reactive stage of M. ulcerans disease, and there was no cross-reaction in patients with other mycobacterioses. On the other hand, the majority of patients with M. ulcerans disease reacting to Burulin also produce positive reactions to Tuberculin PPD.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1054061      PMCID: PMC2131542          DOI: 10.1017/s0022172400046659

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  2 in total

1.  An immunodiffusion analysis of strains of Mycobacterium ulcerans isolated in Australia, Malaya, Mexico, Uganda and Zaire.

Authors:  J L Stanford
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

2.  Mycobacteria, skins, and needles.

Authors:  J Vandepitte; J Desmyter; F Gatti
Journal:  Lancet       Date:  1969-09-27       Impact factor: 79.321

  2 in total
  28 in total

1.  A preliminary study of the effect of contact with environmental mycobacteria on the pattern of sensitivity to a range of new tuberculins amongst Ugandan adults.

Authors:  J L Stanford; R C Paul
Journal:  J Hyg (Lond)       Date:  1976-04

2.  Multiple skin testing of Kenyan schoolchildren with a series of new tuberculins.

Authors:  R C Paul; J L Stanford; O Misljenóvic; J Lefering
Journal:  J Hyg (Lond)       Date:  1975-10

3.  Prophylactic effect of mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli Ulcer).

Authors:  F Portaels; J Aguiar; M Debacker; C Steunou; C Zinsou; A Guédénon; W M Meyers
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

4.  Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection.

Authors:  M J Shield; J L Stanford; R C Paul; J W Carswell
Journal:  J Hyg (Lond)       Date:  1977-06

5.  Skin test responsiveness to four new tuberculins in patients with chronic obstructive airways disease receiving short term high doses of, or long term maintenance treatment with, prednisolone: clinical appearances and histometric studies.

Authors:  J G Lowe; J S Beck; J H Gibbs; R A Brown; R C Potts; J M Grange; J L Stanford
Journal:  J Clin Pathol       Date:  1987-01       Impact factor: 3.411

6.  Infection with Mycobacterium ulcerans induces persistent inflammatory responses in mice.

Authors:  Martinha S Oliveira; Alexandra G Fraga; Egídio Torrado; António G Castro; João P Pereira; Adhemar Longatto Filho; Fernanda Milanezi; Fernando C Schmitt; Wayne M Meyers; Françoise Portaels; Manuel T Silva; Jorge Pedrosa
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 7.  Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans.

Authors:  Caroline Demangel; Timothy P Stinear; Stewart T Cole
Journal:  Nat Rev Microbiol       Date:  2009-01       Impact factor: 60.633

8.  Multiple skin testing in leprosy.

Authors:  R C Paul; J L Stanford; J W Carswell
Journal:  J Hyg (Lond)       Date:  1975-08

9.  Serologic response to culture filtrate antigens of Mycobacterium ulcerans during Buruli ulcer disease.

Authors:  K M Dobos; E A Spotts; B J Marston; C R Horsburgh; C H King
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

10.  Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.

Authors:  Sacha J Pidot; Jessica L Porter; Laurent Marsollier; Annick Chauty; Florence Migot-Nabias; Cyril Badaut; Angèle Bénard; Marie-Therese Ruf; Torsten Seemann; Paul D R Johnson; John K Davies; Grant A Jenkin; Gerd Pluschke; Timothy P Stinear
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.